beta
CELGZ
Celgene Corp.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.
Market Cap:
Primary Exchange: NASDAQ
Website: http://www.celgene.com
Shares Outstanding: 0
Float:
Dividend: 0.0359 (0.06%)
Beta:
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1583 trading days
From: 2013-09-06 To: 2019-11-05
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|